Boston Partners’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-198,827
Closed -$18.3M 707
2024
Q1
$18.3M Sell
198,827
-4,870
-2% -$449K 0.02% 339
2023
Q4
$19.4M Sell
203,697
-8,004
-4% -$761K 0.03% 333
2023
Q3
$19.7M Sell
211,701
-12,534
-6% -$1.17M 0.03% 310
2023
Q2
$20.5M Sell
224,235
-205,004
-48% -$18.8M 0.03% 308
2023
Q1
$32M Buy
429,239
+104,737
+32% +$7.81M 0.04% 261
2022
Q4
$27.7M Buy
324,502
+74,553
+30% +$6.36M 0.04% 266
2022
Q3
$24M Buy
249,949
+47,416
+23% +$4.55M 0.04% 275
2022
Q2
$21.7M Buy
202,533
+128,588
+174% +$13.8M 0.03% 303
2022
Q1
$12.7M Buy
73,945
+67,194
+995% +$11.6M 0.02% 350
2021
Q4
$1.09M Sell
6,751
-679
-9% -$110K ﹤0.01% 521
2021
Q3
$1.11M Buy
+7,430
New +$1.11M ﹤0.01% 512